Pliant Therapeutics

A doctor with a graphic representation of the lungs
Biotech

Pliant ends lung disease program over rise in adverse events

Pliant has terminated its IPF program after digging into the increased rate of adverse events from a 2b/3 trial of its lead candidate bexotegrast.
James Waldron Jun 30, 2025 4:49am
Winding 3D road with dollar bills

Pliant cuts workforce by 45% after bexotegrast trial safety woes

May 2, 2025 7:33am
poison pill toxic poison

Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms

Mar 14, 2025 10:01am
cancelled flights

Pliant terminates lung disease trial due to adverse events

Mar 3, 2025 11:30am
pause hold stop delay

Pliant pauses lung fibrosis trial on advice of safety committee

Feb 10, 2025 4:18am
photo of a paraglider in the foreground with the alps in the background

Flagship vet plants CEO roots at Pharming—Chutes & Ladders

Jan 24, 2025 8:30am